ChairJohn Hatem 

Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Jean Duteau Duteau Design
John Hatem (chair)Independent Consultantx
Jose Costa Teixeira PATHx
Melva PetersJenaker Consulting
Scott Robertson (scribe)Kaiser Permanentex

Danielle BancroftBest Practice Software
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Smile Digital Health
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDP
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHAx
Tim McNeilSurescripts
Kim RobertsPharmacy HIT Collaborative
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna
James Tcheng

Peter Muir

Joe KellySurescripts
Peter Jordan

Giorgio CangioliHL7 Italy
Jeff ShickUSP
Kent BulzaArtera
Sarah Danielson

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from the previous meeting

Project Proposals

Project Proposals in Review - None to review

Project Scope Statements

Project Scope Statements 

May WGM Draft Agenda Review

  • - skipped

External Meeting Review

  • - nothing to report

Catalog Updates (John Hatem)

  • - No meeting last week

Workflow Update (John Hatem)

  •   - No update

Healthcare Product Update (John Hatem)

  • - No update

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)

  • - No meeting this week, next meeting will be the first week of April. 

Project updates

Pharmacy Templates

  • - Georgio has a Publication request document.  It will be discussed and voted on in the March 20th meeting. 

Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)

  • - in good shape.  a number of things require input/work from other groups.  remaining items are minor 

Status state diagram review 

  • John reviewed the mapping between Med dispense status and BDP dispense status.  Suggestion was to send this to the list serve for input. 
    • review of mapping document.  
      • "ready for pickup" (in pharmacy) compares to "allocated" in BDP.
        • BDP "allocated" description is "ready for transport"   
      • "returned" - we don't have it, do we need it (returned after picked up).  usually these are wasted ... but can be reused in some cases. 
        • as opposed to "return to stock," which was "ready for pickup" and not received by patient.
      • pharmacy "completed" - BDP says "issued"
      • pharmacy "stopped" ("failed") - BDP uses "unfulfilled".
      • pharmacy "declined" ("not-done) - maybe BDP "returned" ("abandoned")
    • - Need status update? 
      • John's working on it

Timing questions (Jose)

NCPDP Updates (NCPDP Members)

Pharmacist Consult Note (Scott)

Specialty Medication Enrolment IG

  • - Need status update - have all items below been completed? 

Any Other Business

  • USCDI - Shelly Spiro
    • Quick review of USCDI V4 - adding Medication Instructions and Adherence
    • Possible to add more from the Level 2 medication list
    • question is which, if any, of the Level 2 terms be added to V4.  discussed
      • Negation Reason - probably good to include
      • Medication Administration - 
      • need more info, 
    • book time next week for further discussion, invite Hans (for HITAC).  also invite Margaret (for NCPDP side).  send note to list. -Scott
  • Email from Floyd - pharmacy SIG questions
  •  IHE work items (Jose) - - any updates needed to the items below?  Can they be removed from Agenda?  
    • IHE Pharmacy met - a couple of work items
      • produce profiles for prescription in FHIR - these would be IHE profiles
    • Unicom - identification of medications cross borders
      • querying of product based information
      • use of product information - either medication knowledge or medication definition
    • Medication Overview - medication lists in IHE

Next meeting: